About: Targeting lipid-lowering drug therapy for primary prevention of coronary disease: an updated Sheffield table

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Targeting lipid-lowering drug therapy for primary prevention of coronary disease: an updated Sheffield table Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 August 1996

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в серпні 1996 (uk) im August 1996 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu n'agostu de 1996 (ast) scientific article published on 01 August 1996 (en)
publication date	wds:Q71264443-4E963D73-9AFE-436F-80B5-8BFF519C7950
publication date	1996-08-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q71264443-42AA4073-2FA9-430C-9701-94DA7813D77B
language of work or name	English
cites work	wds:Q71264443-04547D10-46FA-48A3-A606-5738D5037C04 wds:Q71264443-562599B3-4A6E-45A3-9109-F09024DD582D wds:Q71264443-70EE8572-0392-40DD-9918-195C0D9936ED wds:Q71264443-A83C7357-BC5D-464A-B02A-766D2B7EAC2C
cites work	Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group Lipid-lowering for prevention of coronary heart disease: what policy now? Identifying adults at increased risk of coronary disease. How well do the current cholesterol guidelines work? Sheffield risk and treatment table for cholesterol lowering for primary prevention of coronary heart disease
author name string	wds:Q71264443-1E772A6C-DA22-438D-8D54-7CA502733896 wds:Q71264443-497D51E4-64C0-426E-A6D7-F4FDCEEBBBB4 wds:Q71264443-73BFEA21-8079-4807-B3AA-3AABF3209E4B wds:Q71264443-8327A470-ACD2-4942-8C70-E3EAB531C273 wds:Q71264443-E2552817-F05E-4819-AEBF-A855AF57FB0D
author name string	J N Payne I U Haq P R Jackson L E Ramsay D M Pickin
rdfs:label	Targeting lipid-lowering drug therapy for primary prevention of coronary disease: an updated Sheffield table (en) Targeting lipid-lowering drug therapy for primary prevention of coronary disease: an updated Sheffield table (nl)
skos:prefLabel	Targeting lipid-lowering drug therapy for primary prevention of coronary disease: an updated Sheffield table (en) Targeting lipid-lowering drug therapy for primary prevention of coronary disease: an updated Sheffield table (nl)
name	Targeting lipid-lowering drug therapy for primary prevention of coronary disease: an updated Sheffield table (en) Targeting lipid-lowering drug therapy for primary prevention of coronary disease: an updated Sheffield table (nl)
author	wds:Q71264443-D39F6677-8622-4AA7-A03B-AAE273F7F081
author	Wilfred Winston Yeo
title	wds:Q71264443-9E853CC5-0A30-4BF6-AE7E-455007D12859
title	Targeting lipid-lowering drug therapy for primary prevention of coronary disease: an updated Sheffield table (en)
page(s)	wds:Q71264443-E6797B5E-E8F8-43AA-AB49-13C298758C53
page(s)	387-388
instance of	wds:Q71264443-F80A3023-A4BD-41DC-AEBD-00A734E9C28C
instance of	scholarly article
PubMed ID	wds:Q71264443-0ABF21A6-45B8-4AFB-BB0E-D2EF5A787C88
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/8709740
PubMed ID	8709740
published in	wds:Q71264443-6FCF825D-5C31-49A2-A233-8B2A407FA898
published in	The Lancet
issue	wds:Q71264443-F9EA53EB-6001-4588-AFB8-5190C04061A3
volume	wds:Q71264443-4C47EE15-E33E-494B-BF2C-5CB6FFA90BF8
issue	9024
volume	348
DOI	wds:Q71264443-EA9620AD-7309-479C-9FF6-C1E38F9650E5
DOI	http://dx.doi.org/10.1016/S0140-6736(96)05516-X
DOI	10.1016/S0140-6736(96)05516-X
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q71264443
is cites work of	Using disease risk estimates to guide risk factor interventions: field test of a patient workbook for self-assessing coronary risk Ezetimibe for primary hypercholesterolemia Statins for preventing cardiovascular disease Cholesterol and coronary heart disease: screening and treatment Long-term risk stratification for survivors of acute coronary syndromes. Results from the Long-term Intervention with Pravastatin in Ischemic Disease (LIPID) Study. LIPID Study Investigators Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm (ASCOT-LLA): a multicentre ra Prediction of mortality from coronary heart disease among diverse populations: is there a common predictive function? Prediction of coronary heart disease: a comparison between the Copenhagen risk score and the Framingham risk score applied to a Dutch population Applying the Sheffield tables to data from general practice FRAX and the assessment of fracture probability in men and women from the UK Intervention thresholds for osteoporosis in men and women: a study based on data from Sweden Intervention thresholds for osteoporosis Cost effectiveness of HMG-CoA reductase inhibitor (statin) treatment related to the risk of coronary heart disease and cost of drug treatment. Indications for cholesterol-lowering medication: comparison of risk-assessment methods Prediction of Coronary Heart Disease Using Risk Factor Categories Application of cardiovascular disease risk prediction models and the relevance of novel biomarkers to risk stratification in Asian Indians Use of lipid lowering drugs for primary prevention of coronary heart disease: meta-analysis of randomised trials Efficacy of lipid lowering drug treatment for diabetic and non-diabetic patients: meta-analysis of randomised controlled trials A simple computer program for guiding management of cardiovascular risk factors and prescribing Coronary and cardiovascular risk estimation for primary prevention: validation of a new Sheffield table in the 1995 Scottish health survey population Prevention of Coronary and Stroke Events with Atorvastatin in Hypertensive Patients who have Average or Lower-than-Average Cholesterol Concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial— Lipid Lowering Arm (ASCOT-LLA) Investigation and management of stable angina: revised guidelines 1998. Joint Working Party of the British Cardiac Society and Royal College of Physicians of London. Statins for the primary prevention of cardiovascular disease Management of UTI in general practice: a cost effective analysis. A commentary to facilitate an understanding of economic evaluation Is the Framingham risk function valid for northern European populations? A comparison of methods for estimating absolute coronary risk in high risk men Better coronary risk assessment in women Gambling with cardiovascular risk: picking the winners and the losers Economics of drug treatment: for which patients is it costeffective to lower cholesterol? A practical approach to risk assessment to prevent coronary artery disease and its complications Comparative accuracy of cardiovascular risk prediction methods in primary care patients An adaptation of the Framingham coronary heart disease risk function to European Mediterranean areas Comparison of estimates and calculations of risk of coronary heart disease by doctors and nurses using different calculation tools in general practice: cross sectional study Cardiology. Using the Framingham model to predict heart disease in the United Kingdom: retrospective study Framingham-based tools to calculate the global risk of coronary heart disease: a systematic review of tools for clinicians Low prevalence of lipid lowering drug use in older men with established coronary heart disease Comparison of current guidelines for primary prevention of coronary heart disease: risk assessment and lipid-lowering therapy Cardiovascular risk changes after lipid lowering medications: are they predictable? Laboratory-based calculation of coronary heart disease risk in a hospital diabetic clinic. [Coronary risk and prescription in primary care patients with hypercholesterolemia] Statins and hypercholesterolaemia: UK Standing Medical Advisory Committee guidelines Selecting methods for the prediction of future events in cost-effectiveness models: a decision-framework and example from the cardiovascular field The primary prevention of coronary heart disease with statins: practice headache or public health? Cholesterol-lowering therapy for smokers and non-smokers: a life-table analysis Economic implications of lipid-lowering trials: current considerations in selecting a statin

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 172 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software